4//SEC Filing
CORRIGAN MARK 4
Accession 0001104659-22-086277
CIK 0001641640other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 6:19 PM ET
Size
5.0 KB
Accession
0001104659-22-086277
Insider Transaction Report
Form 4
CORRIGAN MARK
Director
Transactions
- Sale
Ordinary Shares
2022-08-02$0.19/sh−10,297$1,956→ 7,203 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.1900 to $0.1911, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Nabriva Therapeutics plc
CIK 0001641640
Entity typeother
Related Parties
1- filerCIK 0001250661
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 6:19 PM ET
- Size
- 5.0 KB